Matches in Wikidata for { <http://www.wikidata.org/entity/Q93022900> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q93022900 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q93022900 description "scientific article published on 25 June 2019" @default.
- Q93022900 description "wetenschappelijk artikel" @default.
- Q93022900 description "наукова стаття, опублікована 25 червня 2019" @default.
- Q93022900 name "Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride" @default.
- Q93022900 name "Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride" @default.
- Q93022900 type Item @default.
- Q93022900 label "Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride" @default.
- Q93022900 label "Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride" @default.
- Q93022900 prefLabel "Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride" @default.
- Q93022900 prefLabel "Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride" @default.
- Q93022900 P1433 Q93022900-35A00D9C-30F7-456B-A6F0-F1A6C0701ACE @default.
- Q93022900 P1476 Q93022900-5C86B130-2E32-46C1-B50D-DF693A7140CE @default.
- Q93022900 P2093 Q93022900-8C44C1BC-3024-4592-9567-CA259C899AC2 @default.
- Q93022900 P2093 Q93022900-EFD3FA7F-4304-4E4B-ADC1-5F7FD30F9011 @default.
- Q93022900 P304 Q93022900-1DB4A171-34FB-4CBC-9CBC-0013C302D635 @default.
- Q93022900 P31 Q93022900-089FC49A-0363-4537-9123-8E119AD6495E @default.
- Q93022900 P356 Q93022900-B84F1F38-B090-49FB-A552-7573CCE4257A @default.
- Q93022900 P433 Q93022900-594FA8F7-8F45-4644-9CD8-7568BB7C7790 @default.
- Q93022900 P478 Q93022900-BFF59605-AAC7-4176-82A0-EDA3A9BA8A1B @default.
- Q93022900 P50 Q93022900-056A292D-D567-4F74-9C02-100C427E3A83 @default.
- Q93022900 P50 Q93022900-31196CB6-CA38-4C55-90DD-07C0B7553489 @default.
- Q93022900 P50 Q93022900-D1930F00-F16C-43A1-AACC-531D89F6788D @default.
- Q93022900 P577 Q93022900-A90DBD35-CB48-456B-97EB-B062A2792CA2 @default.
- Q93022900 P698 Q93022900-0C5F0F6A-5227-4535-8E5F-C0E553FF2F19 @default.
- Q93022900 P921 Q93022900-1086ED9F-FFE1-4E9B-B755-4CE3A608C524 @default.
- Q93022900 P921 Q93022900-7B10F257-C976-4F02-AE09-A3B2299B1BF4 @default.
- Q93022900 P932 Q93022900-992269FF-59D9-4322-A34E-38B1DCCCBE23 @default.
- Q93022900 P356 DC19-0069 @default.
- Q93022900 P698 31239281 @default.
- Q93022900 P1433 Q5270111 @default.
- Q93022900 P1476 "Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride" @default.
- Q93022900 P2093 "David Martin" @default.
- Q93022900 P2093 "Jessica M Franklin" @default.
- Q93022900 P304 "2204-2210" @default.
- Q93022900 P31 Q13442814 @default.
- Q93022900 P356 "10.2337/DC19-0069" @default.
- Q93022900 P433 "12" @default.
- Q93022900 P478 "42" @default.
- Q93022900 P50 Q60162120 @default.
- Q93022900 P50 Q89636660 @default.
- Q93022900 P50 Q91991805 @default.
- Q93022900 P577 "2019-06-25T00:00:00Z" @default.
- Q93022900 P698 "31239281" @default.
- Q93022900 P921 Q42825046 @default.
- Q93022900 P921 Q909745 @default.
- Q93022900 P932 "6868466" @default.